| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/25/2008 | US20080234378 Methods for the preparation and formulation of l-carnitine valproate salts |
| 09/25/2008 | US20080234377 Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
| 09/25/2008 | US20080234375 Process for Decreasing Environmental Pollutants in an Oil or a Fat, a Volatile Environmental Pollutants Decreasing Working Fluid, a Health Supplement, and an Animal Feed Product |
| 09/25/2008 | US20080234368 Therapeutic compositions and methods of use |
| 09/25/2008 | US20080234359 Reducing tumor necrosis factor, phosphodiesterase inhibitor; anticancer agents; leukemia; antidepressants; antiinflammatory agents; respiratory system disorders |
| 09/25/2008 | US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 09/25/2008 | US20080234356 anxiety, depression, epilepsy, schizophrenia, and cognitive disorders; gamma -Aminobutyric acid receptors modulators; 5,7-Di-tert-butyl-3-hydroxy-3-trifluoromethyl-1,3-dihydro-indol-2-one |
| 09/25/2008 | US20080234349 PPAR active compounds |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234338 Neurorestoration With R(+) Pramipexole |
| 09/25/2008 | US20080234334 1,4 diamino bicyclic retigabine analogues as potassium channel modulators |
| 09/25/2008 | US20080234321 1-ethyl-4-[3-fluoro-5-(methylsulfonyl)phenyl]piperidine; central nervous system disorders, Parkinson's disease, Parkinsonism, dyskinesias, including L-DOPA induced dyskinesias, dystonias, tics, tremor, Huntington disease |
| 09/25/2008 | US20080234317 Methods for the improvement of memory and neurological function comprising the administration of compositions that act as inhibitors of the sodium proton (na+ /h+ ) exchanger, subtype 5 (nhe-5) |
| 09/25/2008 | US20080234316 Quinuclidine Amide Derivatives |
| 09/25/2008 | US20080234314 2-(6-bromobenzo[d][1,3]dioxol-5-ylthio)-1-(pent-4-ynyl)-1H-imidazo [4,5-c]pyridin-4-amine; cancer, an autoimmune disease, or a neurodegenerative disease; ubiquitous chaperone protein inhibitors |
| 09/25/2008 | US20080234313 Novel inhibitors |
| 09/25/2008 | US20080234311 IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES |
| 09/25/2008 | US20080234307 Novel 6-Amino-Morphinan Derivatives, Method of Manufacturing Them and Their Application as Analgesics |
| 09/25/2008 | US20080234306 (S)-17-Cyclopropylmethyl-4,5 alpha -epoxy-3,14-dihydroxymorphinan N-oxide and an opioid agonist; significant mu-opioid receptor antagonistic activity; reducing opioid side-effects, dysphoria, pruritis, urinary retention, nausea, emesis |
| 09/25/2008 | US20080234301 Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases |
| 09/25/2008 | US20080234296 Triazolo[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists |
| 09/25/2008 | US20080234283 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases |
| 09/25/2008 | US20080234282 Especially 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives: 4-{[2-(3,chloro-4-fluorophenyl)-2-piperazin-1-ylethoxy]methyl}-3-methoxy-2-naphthonitrile; neurokinin 1 antagonists; antidepressants |
| 09/25/2008 | US20080234274 Novel Compounds |
| 09/25/2008 | US20080234269 N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands |
| 09/25/2008 | US20080234259 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant |
| 09/25/2008 | US20080234253 Alzheimer's disease, stroke, traumatic brain injury, and depression, neurodegenerative diseases; antidepressants; a phenyl thiourea or urea derivatives; promote cell proliferation of stem or progenitor cells |
| 09/25/2008 | US20080234247 Heterocyclic analgesic compounds and methods of use thereof |
| 09/25/2008 | US20080234243 Method of treating amyloidosis mediated diseases |
| 09/25/2008 | US20080234237 selectively inhibit neuronal nitric oxide synthase in combination with other pharmaceutically active agents; antidepressants |
| 09/25/2008 | US20080234233 N-arylsalicylamide derivatives and hydroxyaryl derivatives; inhibitory activities against AP-1 activation and against NF- kappa B |
| 09/25/2008 | US20080234218 Sirna For Inhibiting Il-6 Expression and Composition Containing Them |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234202 Reacting carboxylic acid or amide derivative with amine compound to obtain amino acid analogs, peptides containing analogs of basic amino acids lysine and arginine; desamino amino acid compound, of the extended or truncated peptide; pain, psychosis, obesity; cosmetics |
| 09/25/2008 | US20080234197 Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF) |
| 09/25/2008 | US20080234196 First series of intranasal administration of E-selectin over period of two weeks, followed by a booster administration of E-selectin after at least two weeks from the first administration of E-selectin to minimize brain tissue damage |
| 09/25/2008 | US20080234190 Administering a glial growth factor protein to treat nervous system conditions associated with demyelination, especially of Schwann cells; multiple sclerosis |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080233651 Method and medicament for inhibiting the expression of a given gene |
| 09/25/2008 | US20080233649 Progenitor cells; serum-free; differentiation; cloning |
| 09/25/2008 | US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 09/25/2008 | US20080233625 Dietary supplements for regulating the central nervous system |
| 09/25/2008 | US20080233223 Preparing extract which does not cause allergies, wherein active ingredients of Rhus verniciflua can be obtained with high yield while completely removing the allergy-inducing components, by repeating extraction with a series of specific solvents and drying; treatment of dementia |
| 09/25/2008 | US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease) |
| 09/25/2008 | US20080233163 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease |
| 09/25/2008 | US20080233112 Treatment of Diseases |
| 09/25/2008 | US20080233098 For regulation of growth of neurons in the Central Nervous System; delivering a dominant negative RhoA to the nerve growth environment of the patient, stimulating axon growth of a damaged neuronal axon; exoenzyme C3( ADP-ribosyltransferase) or Y27632 |
| 09/25/2008 | US20080233078 Therapeutic polyesters and polyamides |
| 09/25/2008 | DE59410246C5 Pharmazeutische formulierung zur prophylaxe bzw. vorbehandlung einer vergiftung durch phosphororganische cholinesterasehemmer Pharmaceutical formulation for the prophylaxis or pre-treatment of poisoning by organophosphorus cholinesterase inhibitors |
| 09/25/2008 | DE102007014947A1 Stabilisierte wässrige Lösungen von Ergolinverbindungen The stabilized aqueous solutions of ergoline compounds |
| 09/25/2008 | DE102007014286A1 Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung Fluorine-substituted amphetamines and amphetamine derivatives and their use |
| 09/25/2008 | DE102007013812A1 New 1-azacycloalkylimidazole derivatives useful for treating cancer, malaria, cardiovascular diseases or Alzheimer's disease |
| 09/25/2008 | CA2684985A1 Combination of a narcotic and a non-narcotic analgesic |
| 09/25/2008 | CA2684592A1 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine |
| 09/25/2008 | CA2681522A1 Cyclic receptor-associated protein (rap) peptides |
| 09/25/2008 | CA2681506A1 Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
| 09/25/2008 | CA2681466A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 09/25/2008 | CA2681174A1 Magnesium compositions and uses thereof |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/24/2008 | EP1972628A1 Indolizines and aza-analog derivatives thereof as CNS active compounds |
| 09/24/2008 | EP1972342A1 Pharmaceutical compositions comprising a tungsten salt (vi) for the treatment of neurodegenerative disorders, particularly alzheimer's disease and schizophrenia |
| 09/24/2008 | EP1971867A2 Method of identifying compounds useful to treat neuronal degenerative diseases |
| 09/24/2008 | EP1971609A1 Thienopyridine derivatives as modulators of metabotropic glutamate receptors |
| 09/24/2008 | EP1971598A1 Beta-secretase modulators and methods of use |
| 09/24/2008 | EP1971593A2 Improved synthesis and preparations of duloxetine salts |
| 09/24/2008 | EP1971370A1 Oral s-adenosylmethionine compositions |
| 09/24/2008 | EP1971369A2 Combination of anticholinergics, glucocorticoids, beta2-agonists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| 09/24/2008 | EP1971343A2 Treatment of substance abuse |
| 09/24/2008 | EP1971334A2 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction |
| 09/24/2008 | EP1831152B1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 09/24/2008 | EP1799227A4 Therapeutic agents targeting the nc ca-atp channel and methods of use thereof |
| 09/24/2008 | EP1696922B1 Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| 09/24/2008 | EP1594833B1 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 09/24/2008 | EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1408986B1 Proteomimetic compounds and methods |
| 09/24/2008 | EP1385544B1 Humanized antibodies |
| 09/24/2008 | EP1254658B1 Remedies for the treatment of nerve diorders |
| 09/24/2008 | EP1027040B1 Use of mitoguazone dihydrochloride for treating macrophage-associated diseases |
| 09/24/2008 | CN101273064A Anti-TrkB monoclonal antibodies and uses thereof |
| 09/24/2008 | CN101273046A Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 09/24/2008 | CN101273045A 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5-amine |
| 09/24/2008 | CN101273043A Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
| 09/24/2008 | CN101273040A Oxadiazolyl pyrazolo-pyrimidines as MGLUR2 antagonists |
| 09/24/2008 | CN101273037A New compounds for the treatment of neurological, psychiatric or pain disorders |
| 09/24/2008 | CN101273018A Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE) |
| 09/24/2008 | CN101273014A 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 09/24/2008 | CN101270362A Novel serine protease genes related to DPPIV |
| 09/24/2008 | CN101270359A Method for preparing recombined human amyloid A beta 42 and application thereof |
| 09/24/2008 | CN101270147A Achyranthes bidentata polypeptide, preparing process and uses |
| 09/24/2008 | CN101270110A Novel sulfonyl substituted benzophenone oxide compounds, prepraring method and application thereof |
| 09/24/2008 | CN101270102A Process for synthesizing parthenolide derivative and uses thereof |
| 09/24/2008 | CN101270080A Process for synthesizing azaperone |
| 09/24/2008 | CN101270070A Method for preparing (S)-alpha-ethyl-2-oxo--1-pyrrolidine ethanamide with high optical purity |
| 09/24/2008 | CN101269222A Smell concealing composition of hydrochloric selegiline, and preparation containing the composition |
| 09/24/2008 | CN101269210A Ketogenic mix preparation suitable for treating intractable epilepsy |
| 09/24/2008 | CN101269204A Cow-bezoar bolus for resurrection and preparation method thereof |
| 09/24/2008 | CN101269197A Novel article for preventing from being drunk and preparing process |
| 09/24/2008 | CN101269189A Chinese medicinal composition for treating sick headache |
| 09/24/2008 | CN101269188A Traditional Chinese medicine combination for treating parkinsonism and preparation method thereof |